Zerun Biotechnology entered into an Export Agreement of Hepatitis A Vaccine with an Indian biomedical entity

Zerun Biotechnology entered into an Export Agreement of Hepatitis A Vaccine with a well-known Indian biomedical entity on September 6 in New Delhi, India. According to the agreement, the entity will, upon the completion of international registration, distribute Hepatitis A Vaccine in India and other countries for ten years. The execution of the agreement signifies the overall development of Zerun's international business, and Hepatitis A Vaccine and other vaccine products will enter international competitive market. Dr. Wu Ke, the CEO of Zerun signed the agreement for and on behalf of Zerun Company, and CQO Shi Jin, Chang Zhiyuan and Shen Xiaoshu attended the signing ceremony.